Put Options Advised as NYSE:JNJ Miss Sales Forecast

Put Options Advised as NYSE:JNJ Miss Sales Forecast
March 13, 2015

 
It’s not a pretty picture for Johnson & Johnson (NYSE:JNJ) as the company faces headwinds lately from both a fundamental and a technical picture.

On the fundamental side, the strong dollar is cited to be the reason for the recent decline in sales, as otherwise sales would have printed a positive number. Company representatives are saying that 4.5% is the negative dollar impact on its sales. Well, taking that into account together with the fact that the Federal Reserve is about to raise rates, so an even more stronger dollar to come, it means no good news for JNJ in the medium term.

On the fundamental side, recent news and scandals regarding patents seem to be endless as company was ordered by regulators to pay settlements in trials in the United States. The amount in case is not a big one but settles a trend which seems to have no end for the moment.

To the above add the fact that JP Morgan downgraded the stock early 2015 and this puts a negative view on it.

However, above all, the technical picture ahead of Fed rate hike seems to be the big problem.

Failing to stay above the 100 level brings into question the 2014 lows around $96.78 as the whole move since then was corrective and implications are that market will break it.

Therefore, current prices at $99.53 seem to be a good opportunity to buy put options with an expiration date that should stretch beyond Fed March meeting as this should bring levels lower than the 2014 October $96.78.

Andrew Wright

Prior to founding tradersasset.com in 2014, Andrew worked as a proprietary trader, then as a market maker. As a market maker, he traded options in over 100 stocks, he then began trading currency pairs in 2013. Andrew still actively trades both, and prides himself on educating and informing traders on the benefits of both Binary Options and Forex.


Related Articles

F5 Networks to Rise Further on News of Probable Sale

  Last week, F5 Networks, Inc. (NASDAQ:FFIV) saw a 12% appreciation in its share price, following the news that the

Petrobras Turns Bullish on Transparent Pricing Mechanism

  The 61% y-o-y decline in the fiscal 2016 second-quarter net income did not deter the share price of Petroleo

JNJ Signals Uptrend on Attractive Valuations

  To the surprise of investors and even speculators, the stock of consumer and pharmaceutical product manufacturer Johnson & Johnson